Corrigendum to "Parallel explorations in LA-NSCLC: Chemoradiation dose-response optimisation considering immunotherapy and cardiac toxicity sparing" [Radiother. Oncol. 200 (2024) 110477].

IF 4.9 1区医学 Q1 ONCOLOGY Radiotherapy and Oncology Pub Date : 2024-12-14 DOI:10.1016/j.radonc.2024.110666

Huei-Tyng Huang

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

对 "LA-NSCLC 的平行探索：化疗剂量反应优化考虑免疫治疗和心脏毒性疏导" [Radiother.

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Radiotherapy and Oncology 医学-核医学

CiteScore

10.30

自引率

10.50%

发文量

2445

审稿时长

45 days

期刊介绍： Radiotherapy and Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, translational studies, epidemiological outcomes, imaging, dosimetry, and radiation therapy planning, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as data science in radiation oncology and physics aspects relevant to oncology.Papers on more general aspects of interest to the radiation oncologist including chemotherapy, surgery and immunology are also published.

期刊最新文献

Commentary on Bentsen et al.'s study of rib fracture risk after stereotactic body radiotherapy. Response to commentary on "Cumulative rib fracture risk after stereotactic body radiotherapy in patients with localized non-small cell lung cancer" by Tugcu et al. Driving innovation in radiation oncology in a changing world: The Green Journal's roadmap for the next decade. "Cardiovascular toxicities of radiotherapy: From practical issues to new perspectives radiotherapy and Oncology" Marianne C. Aznar, Jutta Bergler-Klein, Giuseppe Boriani, David, J. Cutter, Coen Hurkmans, Mario Levis, Teresa Lopez-Fernandez, Alexander R. Lyon, Maja V. Maraldo. Radiother Oncol. 2024 Aug:197:110336. https://doi.org/10.1016/j.radonc.2024.110336.Epub 2024 may 24. Perfect is the enemy of good: Reply to Struikmans et al.